Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive heart valve products in the Asia...
Announcement marks company's official entry into the US market HONG KONG, June 6, 2017 /CNW/ - OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has...
Launch of Scoreflex™ NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions HONG KONG, Jan. 11, 2017 /CNW/ - OrbusNeich, a global company specializing in the ...
COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced deliverability HONG KONG, Nov. 21, 2016 /CNW/ - OrbusNeich...
The innovator of COMBO™, the world's first dual therapy stent, introduces catheters for lower limb and AV fistula intervention HONG KONG, May 24, 2016 /CNW/ - OrbusNeich, a global company...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.